BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16211284)

  • 1. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
    Qian J; Chen Z; Wang W; Cen J; Xue Y
    Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].
    Qian J; Chen ZX; Wang W; Cen JN; Xue YQ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1260-4. PubMed ID: 15387962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of cell cycle control genes in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases.
    Qian J; Chen Z; Lin J; Wang W; Cen J
    Leuk Res; 2005 Dec; 29(12):1435-41. PubMed ID: 16005964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
    Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
    Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
    Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
    Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of human atrial myocardium with atrial fibrillation by DNA microarray analysis.
    Ohki R; Yamamoto K; Ueno S; Mano H; Misawa Y; Fuse K; Ikeda U; Shimada K
    Int J Cardiol; 2005 Jul; 102(2):233-8. PubMed ID: 15982490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
    Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M
    Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
    Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
    J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers.
    D'ambrosio C; Akin C; Wu Y; Magnusson MK; Metcalfe DD
    J Allergy Clin Immunol; 2003 Dec; 112(6):1162-70. PubMed ID: 14657877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.
    Qi X; Chen Z; Liu D; Cen J; Gu M
    Int J Mol Med; 2008 Jul; 22(1):61-8. PubMed ID: 18575777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
    Kurata M; Hasegawa M; Nakagawa Y; Abe S; Yamamoto K; Suzuki K; Kitagawa M
    Exp Mol Pathol; 2006 Dec; 81(3):249-54. PubMed ID: 16566920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
    Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
    Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman-Diamond syndrome.
    Rujkijyanont P; Beyene J; Wei K; Khan F; Dror Y
    Br J Haematol; 2007 Jun; 137(6):537-44. PubMed ID: 17539775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis.
    Felix RS; Colleoni GW; Caballero OL; Yamamoto M; Almeida MS; Andrade VC; Chauffaille Mde L; Silva WA; Begnami MD; Soares FA; Simpson AJ; Zago MA; Vettore AL
    Cancer Lett; 2009 Jun; 278(1):41-8. PubMed ID: 19171422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
    Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders.
    Cortelezzi A; Colombo G; Pellegrini C; Silvestris I; Moronetti Mazzeo L; Bosari S; Lambertenghi Deliliers G; Fracchiolla NS
    Am J Hematol; 2008 Jul; 83(7):531-9. PubMed ID: 18383321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.